To find out the effect of Lu AF82422 on disease progression in participants with multiple system atrophy.
- Investigator
- Nikolaus McFarland
- Status
- Accepting Candidates
- Ages
- 40 Years - 75 Years
- Sexes
- All
Research at a glance
Top areas of exploration
- Parkinson Disease , 43 publications
- Supranuclear Palsy, Progressive , 18 publications
- Multiple System Atrophy , 14 publications
- Parkinsonian Disorders , 13 publications
Research activity
Focus
Dr. McFarland is a member of the Norman Fixel Institute for Neurological Diseases and the Center for Translational Research in Neurodegenerative Disease (CTRND), which aims to bring the bench research closer to the bedside. His research focuses on understanding the pathological mechanisms of Parkinson disease and related disorders, and on identifying novel biomarkers for early detection and tracking of disease and therapeutic development. A primary goal of his research is to identify and to develop potential novel therapeutics for Parkinson disease and related disorders. His research extends also to the clinic where he is actively involved in multiple clinical trials for atypical Parkinson disorders and Huntington disease.
Active clinical trials
A35-009 (ORION) is a Phase 2b/3 trial to evaluate the efficacy and safety of AMX0035 in participants with Progressive Supranuclear Palsy (PSP), consisting of randomized, double blind placebo controlled phases, followed by an optional open-label…
- Investigator
- Nikolaus McFarland
- Status
- Accepting Candidates
- Ages
- 40 Years - 80 Years
- Sexes
- All
This is a Phase 2, double-blind, parallel-group, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of multiple doses of ONO-2808 in patients with MSA. This is the first study of ONO-2808 in…
- Investigator
- Nikolaus McFarland
- Status
- Accepting Candidates
- Ages
- 30 Years - 80 Years
- Sexes
- All
My publications
Filter publications
97 publications
2020
Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism.
Movement disorders : official journal of the Movement Disorder Society
•2020
Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalence.
Journal of the neurological sciences
•2019
A turn for the worse: Turning performance in Parkinson's disease and Essential tremor.
Clinical biomechanics (Bristol, Avon)
•2019
Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study.
The Lancet. Digital health
•2019
Development of a transcallosal tractography template and its application to dementia.
NeuroImage
•